标题
Engineered Bivalent Ligands to Bias ErbB Receptor-mediated Signaling and Phenotypes
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 286, Issue 31, Pages 27729-27740
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2011-05-27
DOI
10.1074/jbc.m111.221093
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells
- (2010) Qing Sheng et al. CANCER CELL
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- (2010) Alexa B. Turke et al. CANCER CELL
- An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation
- (2010) B. Schoeberl et al. CANCER RESEARCH
- HER3 Comes of Age: New Insights into Its Functions and Role in Signaling, Tumor Biology, and Cancer Therapy
- (2010) M. R. Campbell et al. CLINICAL CANCER RESEARCH
- Mechanisms of resistance to HER family targeting antibodies
- (2010) Tim J. Kruser et al. EXPERIMENTAL CELL RESEARCH
- Kinase-mediated quasi-dimers of EGFR
- (2010) Erez M. Bublil et al. FASEB JOURNAL
- WhitherHER2-Related Therapeutics?
- (2010) Pradip De et al. JOURNAL OF CLINICAL ONCOLOGY
- Spatial control of EGF receptor activation by reversible dimerization on living cells
- (2010) Inhee Chung et al. NATURE
- ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation
- (2010) Fumin Shi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- From combinatorial peptide selection to drug prototype (II): Targeting the epidermal growth factor receptor pathway
- (2010) M. Cardo-Vila et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tailored cancer immunotherapy using combinations of chemotherapy and a mixture of antibodies against EGF-receptor ligands
- (2010) Moshit Lindzen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resiliency and Vulnerability in the HER2-HER3 Tumorigenic Driver
- (2010) D. N. Amin et al. Science Translational Medicine
- Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
- (2009) Teemu T. Junttila et al. CANCER CELL
- Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer
- (2009) T. Yamada et al. CLINICAL CANCER RESEARCH
- Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
- (2009) W. Wang et al. CLINICAL CANCER RESEARCH
- HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells
- (2009) Marta Soler et al. INTERNATIONAL JOURNAL OF CANCER
- Regulation of ErbB2 Receptor Status by the Proteasomal DUB POH1
- (2009) Han Liu et al. PLoS One
- Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3
- (2009) N. Jura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantification of ErbB3 receptor density on human breast cancer cells, using a stable radio-labeled mutant of NRG1beta
- (2008) Sebastian P. van der Woning et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Higher-Order Association States of Cellular ERBB3 Probed with Photo-Cross-Linkable Aptamers†
- (2008) Euisun Park et al. BIOCHEMISTRY
- Surface-Anchoring of Spontaneously Dimerized Epidermal Growth Factor for Highly Selective Expansion of Neural Stem Cells
- (2008) Tadashi Nakaji-Hirabayashi et al. BIOCONJUGATE CHEMISTRY
- Ligand-induced ErbB receptor dimerization
- (2008) Mark A. Lemmon EXPERIMENTAL CELL RESEARCH
- All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells
- (2008) R.-H. Tao et al. JOURNAL OF CELL SCIENCE
- The epidermal growth factor receptor ligands at a glance
- (2008) Marlon R. Schneider et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Systems-Level Analysis of ErbB4 Signaling in Breast Cancer: A Laboratory to Clinical Perspective
- (2008) C.-P. Chuu et al. MOLECULAR CANCER RESEARCH
- Multipathway Model Enables Prediction of Kinase Inhibitor Cross-Talk Effects on Migration of Her2-Overexpressing Mammary Epithelial Cells
- (2008) N. Kumar et al. MOLECULAR PHARMACOLOGY
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now